(Q37960351)

26 August 2017

title

Prevalence of left-ventricular hypertrophy in hypertension: an updated review of echocardiographic studies (English)

1 reference

26 August 2017

main subject

arterial hypertension

0 references

1 reference

C Cuspidi

1

1 reference

26 August 2017

C Sala

2

1 reference

26 August 2017

F Negri

3

1 reference

26 August 2017

G Mancia

4

1 reference

26 August 2017

A Morganti

5

1 reference

26 August 2017

Italian Society of Hypertension

6

1 reference

26 August 2017

publication date

24 November 2011

1 reference

Journal of Human Hypertension

26 August 2017

published in

1 reference

26 August 2017

volume

26

1 reference

26 August 2017

issue

6

1 reference

26 August 2017

page(s)

343-349

1 reference

A translational approach to hypertensive heart disease

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.104

Hypertensive left ventricular hypertrophy risk: beyond adaptive cardiomyocytic hypertrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.104

Molecular pathways underlying cardiac remodeling during pathophysiological stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.104

Association of left ventricular hypertrophy with metabolic risk factors: the HyperGEN study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.104

Prognostic implications of left ventricular hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.104

Left ventricular hypertrophy increases cardiovascular risk independently of in-office and out-of-office blood pressure values.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.104

Clinical significance of left ventricular hypertrophy and changes in left ventricular mass in high-risk hypertensive patients: a subanalysis of the Candesartan Antihypertensive Survival Evaluation in Japan trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.104

Risk reduction after regression of echocardiographic left ventricular hypertrophy in hypertension: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.104

Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.104

Left ventricular hypertrophy and clinical outcomes in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.104

Regression of left ventricular mass by antihypertensive treatment: a meta-analysis of randomized comparative studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.104

Impact of different partition values on prevalences of left ventricular hypertrophy and concentric geometry in a large hypertensive population : the LIFE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.104

Gender and the relationship between resting heart rate and left ventricular geometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.104

Prognostic value of left ventricular mass and its evolution during treatment in the Bordeaux cohort of hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.104

Left ventricular mass and cardiovascular morbidity in essential hypertension: the MAVI study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.104

Role of echocardiography and carotid ultrasonography in stratifying risk in patients with essential hypertension: the Assessment of Prognostic Risk Observational Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.104

Prevalence of left ventricular hypertrophy in hypertensive patients without and with blood pressure control: data from the PAMELA population. Pressioni Arteriose Monitorate E Loro Associazioni

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.104

Left ventricular remodeling and renal function in never-treated essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.104

Normalization for body size and population-attributable risk of left ventricular hypertrophy: the Strong Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.104

Serum uric acid and target organ damage in primary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.104

11beta-Hydroxysteroid dehydrogenase type 2 activity is associated with left ventricular mass in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.104

Asymptomatic left ventricular systolic dysfunction in essential hypertension: prevalence, determinants, and prognostic value

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.104

Different impact of the metabolic syndrome on left ventricular structure and function in hypertensive men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.104

Impact of waist circumference on cardiac phenotype in hypertensives according to gender.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.104

A blunted decrease in nocturnal blood pressure is independently associated with increased aortic stiffness in patients with resistant hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.104

Left ventricular geometry, ambulatory blood pressure and extra-cardiac organ damage in untreated essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.104

Association of serum osteoprotegerin with left ventricular mass in African American adults with hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.104

Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.104

Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.104

Studies on left ventricular hypertrophy regression in arterial hypertension: a clear message for the clinician?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.104

Gender differences in regression of electrocardiographic left ventricular hypertrophy during antihypertensive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.104

Mild renal insufficiency is associated with increased left ventricular mass in men, but not in women: an arterial stiffness-related phenomenon--the Hoorn Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.104

The impact of different echocardiographic diagnostic criteria on the prevalence of left ventricular hypertrophy in essential hypertension: the VITAE study. Ventriculo Izquierdo Tension Arterial España.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.104

Left Ventricular Geometry and Survival in Patients With Normal Left Ventricular Ejection Fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.104

Additive Interaction of Metabolic Syndrome and Chronic Kidney Disease on Cardiac Hypertrophy, and Risk of Cardiovascular Disease in Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.104

The role of non-haemodynamic factors of the genesis of LVH

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.104

7 January 2021

Left ventricular hypertrophy versus chronic kidney disease as predictors of cardiovascular events in hypertension: a Greek 6-year-follow-up study

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.104

7 January 2021

Left ventricular concentric geometry during treatment adversely affects cardiovascular prognosis in hypertensive patients

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.104

7 January 2021

Prevalence and determinants of left ventricular hypertrophy and remodelling patterns in hypertensive patients: the St. Petersburg study

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.104

7 January 2021

Type 2 diabetes is associated with left ventricular concentric remodeling in hypertensive patients

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.104

7 January 2021

Left ventricular concentric geometry is associated with impaired relaxation in hypertension: the HyperGEN study

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.104

7 January 2021

Left ventricular diastolic dysfunction in elderly hypertensives: results of the APROS-diadys study

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.104

7 January 2021

Prevalence and correlates of left ventricular hypertrophy in the African American Study of Kidney Disease Cohort Study

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.104

7 January 2021

Relationships between metabolic syndrome and left ventricular mass in hypertensive patients: does sex matter?

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.104

7 January 2021

Left ventricular hypertrophy detection and body mass index in essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.104

7 January 2021

Does Information on Systolic and Diastolic Function Improve Prediction of a Cardiovascular Event by Left Ventricular Hypertrophy in Arterial Hypertension?

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.104

7 January 2021

Prevalence and severity of echocardiographic left ventricular hypertrophy in hypertensive patients in clinical practice

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.104

7 January 2021

New insights into the relationship of left ventricular geometry and left ventricular mass with cardiac function: A population study of hypertensive subjects

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.104

7 January 2021

Left ventricular mass in hypertensive patients with mild-to-moderate reduction of renal function

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.104

7 January 2021

Controversies in the assessment of left ventricular mass

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.104

7 January 2021

Echocardiographic criteria for left ventricular hypertrophy: the Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.104

7 January 2021

Influence of left ventricular geometric patterns on prognosis in patients with or without coronary artery disease

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.104

7 January 2021

Blood pressure control in Italy: results of recent surveys on hypertension

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.104

7 January 2021

Identifiers

DOI

10.1038/JHH.2011.104

1 reference

26 August 2017

1 reference